Skip to content
Monday, October 12, 2026 Market moodNeutral−6.1
Sign in
GlideslopeGlideslopeGlideslope AI-powered market news
GlideslopeGlideslopeGlideslope
Market mood−6.1
Breaking
CNBC BUSINESS McDonald's is leaning into chicken and drinks to grow. New data shows it could be a tough… Strong Bullish NEW YORK TIMES BUSINESS How American Retirees at Different Incomes Rely on Social Security Bearish YOUTUBE - PBD PODCAST Trump Goes OFF On Zelenskyy Neutral THE DAILY CALLER Pro-2A Orgs Celebrate ATF’s Suppressor Guidance, But Caution Its Not ‘Permanent Fix’ Pessimistic FOX NEWS WORLD Zelenskyy accuses Putin of defying Trump's ceasefire push, sends pointed message to White… Bullish NEW YORK TIMES BUSINESS Europeans Have a Love-Hate Relationship With Chinese Cars Neutral THE DAILY CALLER Darline Graham On Ending Iran War: ‘Why In The World Would We Stop Now?’ Bearish DEFENSE NEWS Airport training site in Laos extends China’s clout in Southeast Asia Neutral CONSTRUCTION DIVE Blue Origin, PPG and more invest in manufacturing facilities Strong Bullish CNBC BUSINESS Delta delays debut of Saudi Arabia service until March after Riyadh airport attacks Neutral CBS NEWS Ilhan Omar's D.C. home searched by Homeland Security investigators, sources say Neutral CBS MONEY WATCH Are banks, USPS and stock markets open on Columbus Day? Neutral CNBC BUSINESS Starbucks says it is not buying Chipotle after takeover speculation Neutral THE GUARDIAN BUSINESS Nobel Prize for economics awarded to Hall and Woodford for work on ‘smoothing’ crises Pessimistic DEFENSE NEWS Powerus unveils fully autonomous drone interceptors Pessimistic COINTELEGRAPH XRP treasury Evernorth’s shares rise 5% at Nasdaq opening print Pessimistic FREIGHTWAVES The Hidden Business Risk Inside Fleet Compliance Neutral BUSINESS INSIDER What Alexandr Wang says he learned from Mark Zuckerberg's 'really long' WhatsApp DMs Neutral CBS NEWS Joe Manganiello opens up about his private battle with a mystery illness Neutral CNBC TOP STORIES Buy the dip on this satellite stock as catalysts line up, says Deutsche Bank Pessimistic CNBC BUSINESS McDonald's is leaning into chicken and drinks to grow. New data shows it could be a tough… Strong Bullish NEW YORK TIMES BUSINESS How American Retirees at Different Incomes Rely on Social Security Bearish YOUTUBE - PBD PODCAST Trump Goes OFF On Zelenskyy Neutral THE DAILY CALLER Pro-2A Orgs Celebrate ATF’s Suppressor Guidance, But Caution Its Not ‘Permanent Fix’ Pessimistic FOX NEWS WORLD Zelenskyy accuses Putin of defying Trump's ceasefire push, sends pointed message to White… Bullish NEW YORK TIMES BUSINESS Europeans Have a Love-Hate Relationship With Chinese Cars Neutral THE DAILY CALLER Darline Graham On Ending Iran War: ‘Why In The World Would We Stop Now?’ Bearish DEFENSE NEWS Airport training site in Laos extends China’s clout in Southeast Asia Neutral CONSTRUCTION DIVE Blue Origin, PPG and more invest in manufacturing facilities Strong Bullish CNBC BUSINESS Delta delays debut of Saudi Arabia service until March after Riyadh airport attacks Neutral CBS NEWS Ilhan Omar's D.C. home searched by Homeland Security investigators, sources say Neutral CBS MONEY WATCH Are banks, USPS and stock markets open on Columbus Day? Neutral CNBC BUSINESS Starbucks says it is not buying Chipotle after takeover speculation Neutral THE GUARDIAN BUSINESS Nobel Prize for economics awarded to Hall and Woodford for work on ‘smoothing’ crises Pessimistic DEFENSE NEWS Powerus unveils fully autonomous drone interceptors Pessimistic COINTELEGRAPH XRP treasury Evernorth’s shares rise 5% at Nasdaq opening print Pessimistic FREIGHTWAVES The Hidden Business Risk Inside Fleet Compliance Neutral BUSINESS INSIDER What Alexandr Wang says he learned from Mark Zuckerberg's 'really long' WhatsApp DMs Neutral CBS NEWS Joe Manganiello opens up about his private battle with a mystery illness Neutral CNBC TOP STORIES Buy the dip on this satellite stock as catalysts line up, says Deutsche Bank Pessimistic
New York Post Business · Sep 24, 2026 5:15 PM EDT Healthcare

FDA approves Eli Lilly’s once-weekly insulin injection for type 2 diabetes

The once-weekly ​treatment could reduce the number of injections by more ⁠than 300 per year compared with once-daily basal insulin, ​Eli Lilly said.

FDA approves Eli Lilly’s once-weekly insulin injection for type 2 diabetes
Image New York Post Business

AI brief

Pulse reads the full article
What happened
Why it matters
What to watch

Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.

Sign in to read the brief
● MACRO ANALYST

Apex+

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.

LOG IN / SUBSCRIBE